Picture of Synlab AG logo

SYAB Synlab AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSuper Stock

Brief: Synlab Continues To Expect AEBITDA Margin To Improve From Its Low Point in 2023

May 8 (Reuters) - SYNLAB AG  SYAB.DE :
    * SYNLAB AG - FOR 2024 SYNLAB CONTINUES TO EXPECT REVENUES
OF
AROUND EUR 2.7 BILLION (AT CURRENT PERIMETER) WITH AN UNDERLYING
ORGANIC GROWTH AROUND 4%.
    * SYNLAB AG - SYNLAB ALSO CONTINUES TO EXPECT AEBITDA MARGIN
TO
IMPROVE FROM ITS LOW POINT IN 2023 WITH A MINIMUM INCREASE OF
50BP.
    * SYNLAB AG - SYNLAB WILL CONTINUE IN 2024 ITS BOLT-ON M&A
STRATEGY WITH AN EXPECTED EV SPENT TO BE WITHIN RANGE OF EUR 50
MILLION TO EUR 100 MILLION
    * SYNLAB AG - YEAR-ON-YEAR INCREASE IN AEBITDA MARGIN WAS
MAINLY
DRIVEN BY 2023 DISPOSALS, A STRONG REBOUND OF PROFITABILITY IN
GERMANY AND COST SAVINGS FROM SALIX INITIATIVES (EUR 8 MILLION)
ACROSS PORTFOLIO

Source text for Eikon:  ID:nEQ9ZdtGMa 
Further company coverage:  SYAB.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Synlab AG

See all news